Literature DB >> 23801931

Genotypes and phenotypes of 162 families with a glomulin mutation.

P Brouillard1, L M Boon, N Revencu, J Berg, A Dompmartin, J Dubois, M Garzon, S Holden, L Kangesu, C Labrèze, S A Lynch, C McKeown, R Meskauskas, I Quere, S Syed, P Vabres, M Wassef, J B Mulliken, M Vikkula.   

Abstract

A decade ago, we identified a novel gene, glomulin (GLMN) in which mutations cause glomuvenous malformations (GVMs). GVMs are bluish-purple cutaneous vascular lesions with characteristic glomus cells in the walls of distended venous channels. The discovery of the genetic basis for GVMs allowed the definition of clinical features to distinguish GVMs from other venous anomalies. The variation in phenotype was also highlighted: from a single punctate blue dot to a large plaque-like lesion. In this study, we screened GLMN in a large cohort of patients to broaden the spectrum of mutations, define their frequency and search for possible genotype-phenotype correlations. Taking into account 6 families published by others, a mutation in GLMN has been found in 162 families. This represents 40 different mutations; the most frequent one being present in almost 45% of them. Expressivity varies largely, without a genotype/phenotype relationship. Among 381 individuals with a mutation, we discovered 37 unaffected carriers, implying a penetrance of 90%. As nonpenetrant individuals may transmit the disease to their descendants, knowledge on the mutational status is needed for appropriate genetic counseling.

Entities:  

Keywords:  Anomaly; Gene; Glomulin; Glomuvenous malformation; Vascular

Year:  2013        PMID: 23801931      PMCID: PMC3666456          DOI: 10.1159/000348675

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  32 in total

1.  Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: evaluation of 126 cases.

Authors:  Rola Al Dhaybi; Julie Powell; Catherine McCuaig; Victor Kokta
Journal:  J Am Acad Dermatol       Date:  2010-12       Impact factor: 11.527

2.  Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations.

Authors:  J Soblet; N Limaye; M Uebelhoer; L M Boon; M Vikkula
Journal:  Mol Syndromol       Date:  2013-03-26

3.  Multiple glomus tumors. A clinical and electron microscopic study.

Authors:  T F Goodman; D C Abele
Journal:  Arch Dermatol       Date:  1971-01

4.  Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect.

Authors:  P Brouillard; M Ghassibé; A Penington; L M Boon; A Dompmartin; I K Temple; M Cordisco; D Adams; F Piette; J I Harper; S Syed; F Boralevi; A Taïeb; S Danda; E Baselga; O Enjolras; J B Mulliken; M Vikkula
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

5.  High-resolution physical and transcript map of the locus for venous malformations with glomus cells (VMGLOM) on chromosome 1p21-p22.

Authors:  P Brouillard; B R Olsen; M Vikkula
Journal:  Genomics       Date:  2000-07-01       Impact factor: 5.736

6.  A novel mutation of the glomulin gene in an Italian family with autosomal dominant cutaneous glomuvenous malformations.

Authors:  Riccardo G Borroni; Nupoor Narula; Marta Diegoli; Maurizia Grasso; Monica Concardi; Renato Rosso; Alessandra Cerica; Valeria Brazzelli; Eloisa Arbustini
Journal:  Exp Dermatol       Date:  2011-12       Impact factor: 3.960

7.  Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities.

Authors:  Laurence M Boon; John B Mulliken; Odile Enjolras; Miikka Vikkula
Journal:  Arch Dermatol       Date:  2004-08

8.  Glomangioma (glomus tumor). A clinicopathologic study with special reference to multiple lesions appearing during pregnancy.

Authors:  C W Laymon; W C Peterson
Journal:  Arch Dermatol       Date:  1965-11

9.  Genetic analysis of a family with hereditary glomuvenous malformations.

Authors:  Anna Ostberg; Gilberto Moreno; Tina Su; Niken Trisnowati; Douglas Marchuk; Dédée F Murrell; Dedee Murrell
Journal:  Australas J Dermatol       Date:  2007-08       Impact factor: 2.875

10.  Elevated D-dimer level in the differential diagnosis of venous malformations.

Authors:  Anne Dompmartin; Fanny Ballieux; Pascal Thibon; Agnès Lequerrec; Cédric Hermans; Philippe Clapuyt; Marie-Thérèse Barrellier; Franck Hammer; Daniel Labbé; Miikka Vikkula; Laurence M Boon
Journal:  Arch Dermatol       Date:  2009-11
View more
  6 in total

1.  Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations.

Authors:  J Soblet; N Limaye; M Uebelhoer; L M Boon; M Vikkula
Journal:  Mol Syndromol       Date:  2013-03-26

2.  Nosological and Theranostic Approach to Vascular Malformation through cfDNA NGS Liquid Biopsy.

Authors:  Viola Bianca Serio; Maria Palmieri; Lorenzo Loberti; Stefania Granata; Chiara Fallerini; Massimo Vaghi; Alessandra Renieri; Anna Maria Pinto
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

3.  Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project.

Authors:  Ozge Ceyhan-Birsoy; Jaclyn B Murry; Kalotina Machini; Matthew S Lebo; Timothy W Yu; Shawn Fayer; Casie A Genetti; Talia S Schwartz; Pankaj B Agrawal; Richard B Parad; Ingrid A Holm; Amy L McGuire; Robert C Green; Heidi L Rehm; Alan H Beggs
Journal:  Am J Hum Genet       Date:  2019-01-03       Impact factor: 11.025

Review 4.  The Many Faces of FKBP51.

Authors:  Andreas Hähle; Stephanie Merz; Christian Meyners; Felix Hausch
Journal:  Biomolecules       Date:  2019-01-21

5.  FKBP51 and FKBP12.6-Novel and tight interactors of Glomulin.

Authors:  Andreas Hähle; Thomas M Geiger; Stephanie Merz; Christian Meyners; Mao Tianqi; Jürgen Kolos; Felix Hausch
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

6.  Genetic syndromes with vascular malformations - update on molecular background and diagnostics.

Authors:  Adam Ustaszewski; Joanna Janowska-Głowacka; Katarzyna Wołyńska; Anna Pietrzak; Magdalena Badura-Stronka
Journal:  Arch Med Sci       Date:  2020-02-25       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.